Nrf2.com
According to an article published by Foxnews entitled ” FDA approves new oral MS drug, Tecfidera” the following information reveals just how big the market is for NRF2 activating medications and supplements. Tecfidera has been FDA approved to treat just one disease, Multiple Sclerosis. From studies published on Pubmed.gov, NRF2 deficiencies is potentially tied to hundreds of additional diseases and illnesses. The statistics and market impact mentioned in this article is a “drop in the bucket” when it comes to the entire potential for the NRF2 activator industry.
Read More
Next Steps
Get Our Free Newsletter
View Resources
Take Our Quiz
PROJECTS COMPLETED
ACTIVE CLIENTS
CUPS OF COFFEE
HAPPY CLIENTS
TESTIMONIALS
What They Say?
SEND US YOUR FEEDBACK
Get a face-to-face appoinment with our qualified specialists
PHONE NUMBER
+ 924 888 0250
EMAIL ADDRESS
hello@spirit.health
OUR LOCATION
Crown Rd. 14b, San Diego, California
© 2021 / Spirit Health / All rights reserved